Objective: We aimed to evaluate the results of stone analysis of the patients with ureter stone and to determine the role of stone analysis in treatment and prevention of recurrence. Material and Methods: The data of the patients who underwent ureterolithotomy for ureter stone between 2003 and 2018 were evaluated retrospectively. X-Ray Diffraction (XRD) method was used in the analysis of the stones. The examined parameters included demographic data, body mass index (BMI), operation type, operative time and stone analysis result. Results: A total of 31 patients (21 male and 10 female) were included in the study. The mean age of the patients was 37.2±12.6 years. The mean stone size was 20.6±6 mm. Ureterolithotomy was performed in 16 (51.6%) patients for right ureter stone and in 15 (48.4%) patients for left ureter stone. Ureterolithotomy was performed laparoscopically in 10 (32.3%) patients and open in 21 (67.7%) patients. The most common stone chemical structure was mix calcium oxalate monohydrate (COMH) and calcium oxalate dihydrate (CODH) with a rate of 32.3%. Uric acid stone was more frequent in patients with diabetes mellitus and hypertension, and the rate of struvite stones was higher in patients with a history of recurrent urinary tract infection (p <0.001). The mean BMI of the patients with uric acid stone was higher than that of the patients with COMH, CODH and struvite stones, but there was no statistically significant difference, 27.8±0.9 kg/m2 versus 24.3±2.4 kg/m2, 22 ±1.4 kg/m2 and 25.2 ±3.3 kg/m2 (p=0.102). Conclusion: Uric acid stone was observed more frequently in patients with metabolic syndrome which ncludes obesity, diabetes mellitus and hypertension components. Stone analysis should be requested from each patient whose stone sample is obtained. In this way, metaphylaxis, which is a set of measures to prevent stone recurrence, can be meaningful.
Keywords: Urolithiasis; ureter stone; ureterolithotomy; stone analysis; x-ray diffraction
Amaç: Üreter taşı nedeniyle üreterolitotomi operasyonu geçiren hastaların taş analizi sonuçlarını değerlendirerek tedavide ve rekürrensin önlenmesinde taş analizinin nasıl bir yeri olabileceğini ortaya koymaya çalıştık. Gereç ve Yöntemler: 2003-2018 yılları arasında üreter taşı nedeniyle üreterolitotomi operasyonu geçiren hastaların verileri retrospektif olarak değerlendirildi. Taşların analizinde X-Ray Difraksiyon (XRD) yöntemi kullanıldı. İncelenen parametreler; hastaların demografik verileri, beden kitle indeksleri (BKİ), operasyon türü, süresi ve taş analizi sonuçlarından oluşmakta idi. Bulgular: Çalışmaya 21'i erkek, 10'u kadın olmak üzere toplam 31 hasta dahil edildi. Hastaların ortalama yaşı 37,2±12,6 yıl idi. Ortalama taş boyutu 20,6±6 mm idi. On altı (%51,6) hastaya sağ üreter taşı, 15 (%48,4) hastaya ise sol üreter taşı sebebiyle üreterolitotomi operasyonu uygulandı. Üreterolitotomi operasyonları 10 (%32,3) hastada laparoskopik, 21 (%67,7) hastada ise açık olarak gerçekleştirildi. En sık saptanan taş kimyasal yapısı %32.3 ile kalsiyum oksalat monohidrat (KOMH) ve kalsiyum oksalat dihidrat (KODH) bileşimi idi. Ürik asit taşı, diabetes mellitus ve hipertansiyonu olan hastalarda daha sık gözlenirken tekrarlayan idrar yolu enfeksiyonu (İYE) hikayesi olan hastalarda strüvit taşı oranı daha fazla idi (p<0,001). Ürik asit taşına sahip olan hastaların ortalama VKİ değeri KOMH, KODH ve strüvit taşı olan hastalardan yüksek olmakla birlikte istatistiksel olarak anlamlı farklılık saptanmamıştır, 27,8±0,9 kg/m2'ye karşı sırasıyla 24,3±2,4 kg/m2, 22 ±1.4 kg/m2 ve 25,2 ±3,3 kg/m2 (p=0,102). Sonuç: Obezite, diyabet ve hipertansiyon bileşenlerinden oluşan metabolik sendromu olan hastalarda ürik asit taşı daha sık gözlenmiştir. Taş numunesi elde edilen her hastadan taş analizi istenmelidir. Bu sayede taş rekürrensini önleyecek önlemler bütünü olan metaflaksi anlam kazanabilir.
Anahtar Kelimeler: Ürolitiyazis; üreter taşı; üreterolitotomi; taş analizi; x ışını difraksiyon
- Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16(5):624-31. [Crossref] [PubMed]
- Leusmann DB, Niggemann H, Roth S, von Ahlen H. Recurrence rates and severity of urinary calculi. Scand J Urol Nephrol. 1995;29(3):279-83. [Crossref] [PubMed]
- Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111(12):1006-9. [Crossref] [PubMed]
- Wu T, Duan X, Chen S, Yang X, Tang T, Cui S. Ureteroscopic lithotripsy versus laparoscopic ureterolithotomy or percutaneous nephrolithotomy in the management of large proximal ureter stones: a systematic review and meta-analysis. Urol Int. 2017;99(3):308-19. [Crossref] [PubMed]
- Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis. 2009;16(1):5-10. [Crossref] [PubMed]
- Karabacak OR, Dilli A, Saltaş H, Yalçınkaya F, Yörükoğlu A, Sertçelik MN. Stone compositions in Turkey: an analysis according to gender and region. Urology. 2013;82(3):532-7. [Crossref] [PubMed]
- Akinci M, Esen T, Tellaloğlu S. Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol. 1991;20(3):200-3. [Crossref] [PubMed]
- Türk C, Knoll T, Petrik A, Sarıca K, Skolarikos A, Straub M, et al. Guidelines on urolithiasis. EAU Guidelines 2013. Available at: http://www.uroweb.org.
- Gök A, Çift A, Gök B, Ener K, Yücel MÖ, Polat H, et al. [Can hounsfield unit value predict type of urinary stones?]. J Clin Anal Med. 2015;6(5):624-7. [Crossref]
- Basiri A, Taheri M, Taheri F. What is the state of the stone analysis tecniques in urolithiasis? Urol J. 2012;9(2):445-54.
- Giannossi ML. The optimal choice for stone analysis. J Xray Sci Technol. 2015;23(3):401-7. [Crossref] [PubMed]
- Kasidas GP, Samuel CT, Weir TB. Renal stone analysis: why and how? Ann Clin Biochem. 2004;41(Pt 2):91-7. [Crossref] [PubMed]
- Douglas DE, Tonks DB. The qualitative analysis of renal calculi with the polarising microscope. Clin Biochem. 1979;12(5):182-3. [Crossref]
- Beischer DE. Analysis of renal calculi by infrared spectroscopy. J Urol. 1955;73(4):653-9. [Crossref]
- Singh I. Renal geology (quantitative renal stone analysis) by 'Fourier transform infrared spectroscopy'. Int Urol Nephrol. 2008;40(3):595-602. [Crossref] [PubMed]
- Kendi S, Kendi E. [Analysis of urinary calculi by X-Ray diffraction method]. Turk J Urol. 1978;4(2):101-3.
- Güneri E, Akkurt M. Qualitative analysis of stone samples taken from some patients with the diseases of urinary system using X-Ray powder diffraction method. G U Journal of Science. 2005;18(3):321-7.
- Kara Ö, Malkoç E, Tonyalı Ş, Ateş F, Uyumaz AS, Özcan Ö, et al. Evaluation of the efficacy of chemical method to determine urinary tract stone composition. South Clin Ist Euras. 2016;27(3):195-9. [Crossref]
- Yapanoğlu T, Demirel A, Adanur Ş, Yüksel H, Polat Ö. X-ray diffraction analysis of urinary tract stones. Turk J Med Sci. 2010;40(3):415-20.
- Muslumanoglu AY, Binbay M, Yuruk E, Akman T, Tepeler A, Esen T, et al. Updated epidemiologic study of urolithiasis in Turkey I: changing characteristics of urolithiasis. Urol Res. 2011;39(4):309-14. [Crossref] [PubMed]
- Binbay M, Yuruk E, Akman T, Sari E, Yazici O, Ugurlu IM, et al. Updated epidemiologic study of urolithiasis in Turkey II: role of metabolic syndrome components on urolithiasis. Urol Res. 2012;40(3):247-52. [Crossref] [PubMed]
.: Process List